Repligen Corp
RGEN Real Time Price USDRecent trades of RGEN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by RGEN's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
- $34,420 2024-09-16 00:00:00 Agency: Department of Health and Human Services
- $34,420 2024-09-16 00:00:00 Agency: Department of Health and Human Services
- $30,465 2022-03-14 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $23,988 2020-09-29 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $4,027 2020-09-11 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $42,538 2020-05-20 Agency: DEPARTMENT OF DEFENSE (DOD)
- $19,763 2020-04-14 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $26,799 2020-03-09 Agency: DEPARTMENT OF DEFENSE (DOD)
Estimated quarterly amount awarded from public contracts
Number of mentions of RGEN in WallStreetBets Daily Discussion
Recent insights relating to RGEN
Recent picks made for RGEN stock on CNBC
ETFs with the largest estimated holdings in RGEN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RGEN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.